XERS - Xeris Pharmaceuticals Inc. (XERS) CEO Paul Edick on Q3 2020 Results - Earnings Call Transcript
Xeris Pharmaceuticals, Inc. (XERS) Q3 2020 Earnings Conference Call November 9, 2020 8:30 AM ET Company Participants Allison Wey - Senior Vice President of Investor Relations and Corporate Communication Paul Edick - Chairman and Chief Executive Officer Barry Deutsch - Chief Financial Officer Conference Call Participants Ami Fadia - Leerink Randall Stanicky - RBC Capital Markets David Amsellem - Piper Sandler Difei Yang - Mizuho Securities Ed Chung - Jefferies Presentation Operator Ladies and gentlemen, thank you for standing by. And welcome to today's Xeris Pharmaceuticals Third Quarter Financial Results. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] I’d now like to hand the conference over to your speaker today, Allison Wey, Senior Vice President of Investor Relations and Corporate Communication. Please go ahead. Allison Wey Thank you, Michelle. Good morning and welcome to Xeris’ Third
For further details see:
Xeris Pharmaceuticals, Inc. (XERS) CEO Paul Edick on Q3 2020 Results - Earnings Call Transcript